MedPath

Plan of the Day Radiotherapy

Not Applicable
Recruiting
Conditions
Cervix Cancer
Interventions
Radiation: Plan of the day
Radiation: Standard plan
Registration Number
NCT05634681
Lead Sponsor
Oslo University Hospital
Brief Summary

The study objectives are to improve the treatment of LACC patients and to increase knowledge of the potential benefit of the plan-of-the-day concept on side effects during and after radiotherapy.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
Female
Target Recruitment
190
Inclusion Criteria
  • Histologically confirmed cervical cancer eligible for definitve radiochemotherapy
  • FIGO stage IB1-IVa
  • Over 18 years
  • Speaks and understands Norwegian or English.
  • ECOG 0-2
  • Histology: Squamous cell carcinoma, adenocarcinoma, adenosquamous carcinoma
  • Ability to understand and fill in patient questionnaires, and willing to sign a written informed consent
  • Large movers (LM), fundus movement ≥2,5 cm.
Exclusion Criteria
  • Evidence of distant metastasis. Suspicious paraaortic lymphnodes below the renal vessels is allowed if they are covered by the radiation field
  • Patients with previous surgery for their cervical cancer
  • Uncontrolled intercurrent somatic illness.
  • Psychiatric illness /social situations limiting study compliance
  • Prior radiotherapy to the pelvis
  • Patients who are pregnant or breastfeeding is excluded due to risk of teratogenic and abortifacient effects of radiotherapy and cisplatin, and the potential risk of adverse effect of nursing infants
  • Patients under current treatment for other invasive s except non-melanoma skin cancers
  • Nephrostomy
  • Patients with inflammatory bowel disease

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Intervention armPlan of the day-
Control armStandard plan-
Primary Outcome Measures
NameTimeMethod
To investigate whether implementation of the plan of the day concept results in less gastro-intestinal toxicity.5 weeks

To compare the change in patient reported acute diarrhea from baseline to week 4 from start of the treatment and to the end of external radiotherapy.

Item 17 in EORTC QLQ-C30

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Oslo University Hospital

🇳🇴

Oslo, Norway

© Copyright 2025. All Rights Reserved by MedPath